Abstract

Ternary complexes of histidine amino acid (Schiff base) were synthesized, characterized and tested against multi-drug resistant pathogens. The metal ion centers included Cu (II), Ni (II) and Co (II). These complexes were characterized using physico-chemical and spectroscopic analytical methods. All the complexes are found to be considerably soluble in both polar and non-polar solvents including methanol, ethanol, butanol, acetone, ethyl acetate, and benzene and di ethyl-ether. Electronic Absorption Studies using FT-IR spectrophotometer revealed ν (O-H), ν (C=O), ν (C=N), ν (M -N) and ν (M-O) occurred between 3410 - 3417, 1751 - 1753, 1519 – 1521, 671 – 678, 439 – 470 cm- 1 respectively in complexes and ligand. UV-Visible was further used to elucidate the complexes resulting in transitions characteristics of the ligand and complexes. The Schiff base showed no antimicrobial activity at various therapeutic concentrations. However, the metal complexes exhibited broad spectrum antibiotic activities against the multi-drug resistant pathogens at minimum inhibitory concentration (MIC ≤ 200 µg/ml). The metal complexes showed strong activity against the isolates at medium and high concentrations, the bacteria strains included E.coli , P. aeruginosa, S. typhi and S. aureus and the fungi strains of Candida albicans , Aspergillus flavus and Aspergillus niger . The bioactivity recorded against these multi drug resistant pathogens indicates the potentials of these complexes for further therapeutic studies. Keywords : Histidine complex, synthesis, characterisation, antimicrobial activity, pathogens.

Highlights

  • Antimicrobial resistance to therapeutic drugs is fast becoming a global concern with rapid increase of resistant bacteria

  • Given the disturbing upsurge in infectious maladies instigated by diverse pathogens and the expansion of multi-drug resistance, investigators are examining new different antibacterial representatives

  • Fresh anti-pathogenic representatives with distinct action mechanisms and nano-technological properties have to be synthesized for the treatment of multi-drug resistant bacterial diseases

Read more

Summary

Introduction

Antimicrobial resistance to therapeutic drugs is fast becoming a global concern with rapid increase of resistant bacteria. [1] M. tuberculosis (Strain no: H37Rv ATCC 27294) is showing drug resistance to isoniazid, rifampicin, ethambutol. Aspergillus flavus, Fusarium solani, and Candida glaberata are some fungal pathogens are showing the resistance feature against established drugs. The action mechanism should be different from the current classes of antimicrobial agents and drugs to which many clinically active microbial agents are resistant. Given the disturbing upsurge in infectious maladies instigated by diverse pathogens and the expansion of multi-drug resistance, investigators are examining new different antibacterial representatives. Fresh anti-pathogenic representatives with distinct action mechanisms and nano-technological properties have to be synthesized for the treatment of multi-drug resistant bacterial diseases

Objectives
Methods
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call